Andressa da Matta Durans: She currently holds a FAPERJ postdoctoral fellowship in the Center for Technological Development in Health (CDTS) at the Oswaldo Cruz Foundation (FIOCRUZ). She has a doctorate in Tropical Medicine (2018) from the Oswaldo Cruz Institute of FIOCRUZ under the mentorship of Drs. Angela Junqueira and D. William Provance, Jr for her research to develop a high-performance immunological reagent to diagnose chronic Trypanosoma cruzi infections that are responsible for Chagas disease. She has experience in molecular biology, biotechnology, recombinant proteins, Sanger sequencing and serological diagnosis. During the course of her doctoral research, she contributed to the development of a proteinaceous receptacle as an innovative solution to using linear B-cell in generating immunological reagents. Developed in concert with Drs. Provance, Salvatore Giovanni De Simone and Paloma Napoleão Pêgo at the CDTS, this technology has been submitted as a patent in Brazil with worldwide rights reserved for the bioengineering of chimeric recombinant proteins for use in diagnostic testing, vaccine development and therapeutic antibody production. This bioengineering made viable the construction of chimeric proteins for SARS-CoV-2.